chicago

Eyecelerator @ AAO 2022
Thursday, September 29
McCormick Place, Chicago

PROGRAM AGENDA

*Panels are in development and speakers are subject to change.

Registration + Networking Breakfast

7:00 – 8:00 a.m.

McCormick Place Convention Center, E354

Welcome!

8:00 – 8:10 a.m.

Program Chair Gil Kliman, MD

Program Co-Chairs Allen C. Ho, MD and Julie Schallhorn, MD 

A Wild Ride: 2022 in Review 

8:10 – 9:00 a.m.

Moderator: Stephen D. McLeod, MD
CEO, American Academy of Ophthalmology

How Will the 2022 Midterm Elections Impact Healthcare?

  • Jeffrey Kimbell, President & CEO, Kimbell & Associates 
    Political insider Jeff Kimbell prognosticates on the outcomes of the 2022 and 2024 US elections and the potential impact on the life sciences community.


Ophthalmology Year in Review

  • Kristen Harmon Ingenito, Director of Ophthalmics, Market Scope  
    Start the day with a data-driven and sometimes surprising look at the business of Ophthalmology.

Panel:
  • Wiley A. Chambers, MD, Food & Drug Administration
  • Malvina B. Eydelman, MD, Food & Drug Administration
  • Andrew Gitkin, Raymond James
  • Peter Menziuso, Company Group Chairman, Johnson & Johnson Vision
  • Euan S. Thomson, PhD, President, Ophthalmic Devices and Head of Digital Business, Carl Zeiss Meditec
     

Old Money/New Money: Financing Innovation

9:00 – 9:30 a.m.

Moderator: Gil Kliman, MD

A diverse, multigenerational panel of investment experts explore the interdependent roles of venture capital, private financing and global strategics in funding the next wave of eye care innovation.


Panel: 

  • Franck Leveiller, Alcon

  • William Link, PhD, Flying-L-Partners

  • Mariam Maghribi, PhD, MBA, Shifamed

  • Biren Mehta, Venture Investments, Johnson & Johnson 

  • Jeffry Weinhuff, Visionary Ventures
     

Networking Break 

9:30 – 10:00 a.m.

Enjoy refreshments and connect with your colleagues.
 

Presbyopic Treatment: Where We Go From Here

10:00 – 10:45 a.m.

A  timely assessment of the real-world data driving a new generation of treatments and medical vs. surgical solutions for patients.

 

Moderators: Zaina Al-Mohtaseb, MD and Julie Schallhorn, MD
 

Panel:

  • Jeannette Bankes, Alcon

  • Sumit Garg, MD, LensGen

  • Yari L. Mitchell, AcuFocus, Inc.

  • Erin Powers, BVI Medical 

  • Neda Shamie, MD, Visus Therapeutics  

  • Ramin Valian, Allergan, an AbbVie Company
     

The Future of AMD

10:45 – 11:45 a.m.

Seven innovative retina and AI companies will showcase the newest treatments and technologies, while panel experts analyze the clinical and market opportunities.

 

Moderators: Robert L. Avery, MD and Allen C. Ho, MD

Panel:

  • Megan Baldwin, PhD, Opthea 

  • Durga Borkar, MD, Verana 

  • Wiley A. Chambers, MD, Food & Drug Administration

  • Pravin Dugel, MD, IvericBio

  • Cedric Francois, MD, PhD, Apellis 

  • Kester Nahen, PhD, Notal Vision, Inc. 

  • Stephen Pakola, MD, RegenXBio

Presentations: 

 

  • Apellis, Cedric Francois, MD, PhD, Co-Founder and CEO 
     

  • IvericBio Dhaval B. Desai, SVP & Chief Development Officer
     

  • Gyroscope, a Novartis Company, J. Jill Hopkins, MD, FRSCS, SVP, Global Head Ophthalmology Development Unit 
     

  • RegenXBio, Stephen Pakola, MD, Chief Medical Officer 
     

  • Opthea, Megan Baldwin, PhD, CEO and Managing Director
     

  • Verana, Durga Borkar, MD, Medical Advisor
     

  • Notal Vision, Inc., Kester Nahen, PhD, CEO

Defining Clinically Relevant Endpoints in Approval Trials

11:45 a.m. – 12:30 p.m.

Government, academic, and industry experts offer perspectives on benchmarking practices that accurately characterize the effectiveness of treatments in clinical studies and meet regulatory requirements.
 

Moderators: Mark S. Humayun, MD, PhD and Arsham Sheybani, MD

Panel:

  • Mark S. Blumenkranz, MD, MMS, Byers Eye Institute at Stanford University 

  • Wiley A. Chambers, MD, Food & Drug Administration

  • Terry Dagnon, Outlook Therapeutics

  • Malvina B. Eydelman, MD, Food & Drug Administration

  • Peter K. Kaiser, MD, Cleveland Clinic Lerner College of Medicine

  • Omar Sadaruddin, MD, Santen

  • Matt Schlenker, MS, MD, University of Toronto 
     

Lunch and Networking Break

12.:30  – 1:15 p.m.

Buffet served.
 

The Winning Pitch Challenge 

1:15 – 2:00 p.m. 

The 'Shark Tank' -styled competition returns to the Eyecelerator stage. Three early-stage companies will compete for free access to experienced mentors, networking opportunities, exposure to financial resources, and up to $45,000 in prize money. 

Moderators: John P. Berdahl, MD and Vance M. Thompson, MD

 

Pitch Finalists
 

  • Vincente Diaz, MD, MBA, Sustained Drug Delivery

  • Alejandro Navas, MD, PhD, FACS, New Sight Pharma
     

  • Sunil Patel MD, PhD, Allgenesis Biotherapeutics


Panel Judges: 

  • Vartan Ghazarossian, PhD, CEO, Stepwise Medical 

  • Ranya G. Habash, MD, CEO, Lifelong Vision   

  • Richard L. Lindstrom, MD, Founder, Minnesota Eye Consultants

  • William J. Link, PhD, Managing Partner, Flying-L Partners

Presenting Company Showcase:
Retina,
Therapeutics, and Technology + Devices         

2:00 – 3:55 p.m. 

A diverse line up of 40+ companies, more than half appearing at Eyecelerator for the first time, will present novel treatments and technologies at all stages of production in a unique, interactive format. Audience members are invited to ask questions. 

 

Breakout rooms will operate simultaneously for each segment. Follow these links for showcase schedules:

 

RETINA SHOWCASE

 

THERAPEUTICS SHOWCASE: IMPLANTS AND PHARMACEUTICALS

 

TECHNOLOGY AND DEVICES SHOWCASE

Networking Break

3:55 – 4:15 p.m. 

Find refreshments and connect with your colleagues.
 

Generation Next: Leveling Up a New Wave of Leaders

4:15 – 4:45 p.m.

Moderator Preeya K. Gupta, MD, engages a panel of inspired leaders who are bringing the future of ophthalmology into focus. Each offers a distinct perspective on the industry and the requirements for bringing innovation into the marketplace.

 

Moderator: Preeya K. Gupta, MD

Panelists:

  • Andrew Chang, Global Head of Sales, Ophthalmic Devices, Carl Zeiss Meditec 

  • Ranna Jaraha, Executive Director New Media, BMC 

  • Bindu Manne, Head, Market Development and Commercialization, Ocuphire 

  • Maaza Martin, MS, Senior Director, Marketing, Tarsus Pharmaceuticals

Company Awards and Closing Bell

4:45 – 5:00 p.m. 

Moderators: Allen C. Ho, MD and Julie Schallhorn, MD 
 

Best of Show awards presented